Endothelial nitric oxide synthase gene polymorphisms and the risk of vasculopathy in sickle cell disease

References

• Weatherall DJ. The inherited diseases of hemoglobin are an emerging global health burden. Blood 2010;115:4331–6. doi: 10.1182/blood-2010-01-251348
   PubMed Web of Science ®Google Scholar
• Bunn HF. Sickle hemoglobin and other hemoglobin mutants. In: Stamatoyannopoulos G, Nienhuis AW, Majerus PW, Varmus H, (eds.) The molecular basis of blood diseases. Philadelphia: WB Saunders; 1994. p. 207–56.
   Google Scholar
• Serjeant GR, Serjeant BE, Mohan JS, Clare A. Leg ulceration in sickle cell disease: medieval medicine in a modern world. Hematol Oncol Clin North Am. 2005;19:943–56. doi: 10.1016/j.hoc.2005.08.005
   PubMed Web of Science ®Google Scholar
• Serjeant GR. Sickle cell disease. 2nd ed. Oxford: Oxford University Press; 1992.
   Google Scholar
• Wood KC, Hsu LL, Gladwin MT. Sickle cell disease vasculopathy: a state of nitric oxide resistance. Free Radical Biol Med. 2008;44:1506–28. doi: 10.1016/j.freeradbiomed.2008.01.008
   PubMed Web of Science ®Google Scholar
• Kato GJ, Martyr S, Blackwelder WC, Nichols JS, Coles WA, Hunter LA, et al. Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality. Br J Haematol. 2005;130(6):943–53. doi: 10.1111/j.1365-2141.2005.05701.x
   PubMed Web of Science ®Google Scholar
• Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004;350(9):886–95. doi: 10.1056/NEJMoa035477
   PubMed Web of Science ®Google Scholar
• Bunn HF, Nathan DG, Dover GJ, Hebbel RP, Platt OS, Rosse WF, et al. Pulmonary hypertension and nitric oxide depletion in sickle cell disease. Blood 2010;116(5):687–92. doi: 10.1182/blood-2010-02-268193
   PubMed Web of Science ®Google Scholar
• Sessa WC. eNOS at a glance. J Cell Sci. 2004;117:2427–9. doi: 10.1242/jcs.01165
   PubMed Web of Science ®Google Scholar
• Pritchard Jr. KA, Ou J, Ou Z, Shi Y, Franciosi JP, Signorino P, et al. Hypoxia-induced acute lung injury in murine models of sickle cell disease. Am J Physiol Lung Cell Mol Physiol. 2004;286:705L–14. doi: 10.1152/ajplung.00288.2002
   PubMed Web of Science ®Google Scholar
• Morris CR, Kuypers FA, Larkin S, Vichinsky E, Styles L. Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome. J Pediatr Hematol Oncol. 2000;22:515–20. doi: 10.1097/00043426-200011000-00009
   PubMed Web of Science ®Google Scholar
• Tsukada T, Yokoyama K, Aria T, Takemoto F, Hara S, Yamada A, et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophysics Res Commun. 1998;245:190–3. doi: 10.1006/bbrc.1998.8267
   PubMed Web of Science ®Google Scholar
• Kunnas TA, Ilveskoski E, Niskakangas T, Laippala P, Kajander OA, Mikkelsson J, et al. Association of the endothelial nitric oxide synthase gene polymorphism with risk of coronary artery disease and myocardial infarction in middle-aged men. J Mol Med. 2002;80:605–9. doi: 10.1007/s00109-002-0365-z
   PubMed Web of Science ®Google Scholar
• Wang XL, Wang J. Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol Genet Metab. 2000;70:241–51. doi: 10.1006/mgme.2000.3033
   PubMed Web of Science ®Google Scholar
• Nagase S, Suzuki H, Wang Y, Kikuchi S, Hirayama A, Ueda A, et al. Association of ecNOS gene polymorphisms with end stage renal diseases. Mol Cell Biochem. 2003;244(1–2):113–8. PMID: 12701818 doi: 10.1023/A:1022473405275
   PubMed Web of Science ®Google Scholar
• Endres M, Laufs U, Liao JK, Moskowitz MA. Targeting eNOS for stroke protection. Trends Neurosci. 2004;27:283–9. doi: 10.1016/j.tins.2004.03.009
   PubMed Web of Science ®Google Scholar
• Tarer V, Etienne-Julan M, Diara JP, Belloy MS, Mukizi-Mukaza M, Elion J, et al. Sickle cell anemia in Guadeloupean children: pattern and prevalence of acute clinical events. Eur J Haematol. 2006;76:193–9. doi: 10.1111/j.1600-0609.2005.00590.x
   PubMed Web of Science ®Google Scholar
• Ballas SK, Lieff S, Benjamin LJ, et al. Definitions of the phenotypic manifestations of sickle cell disease. Am J Hematol. 2010;85:6–13. doi: 10.1002/ajh.21750
   PubMed Web of Science ®Google Scholar
• Ambrusko SJ, Gunawardena S, Sakara A, Windsor B, Lanford L, Michelson P, et al. Elevation of tricuspid regurgitant jet velocity, a marker for pulmonary hypertension in children with sickle cell disease. Pediatr Blood Cancer. 2006;47(7):907–13. doi: 10.1002/pbc.20791
   PubMed Web of Science ®Google Scholar
• Guash A, Cua M, Mitch WE. Early detection and the course of glomerular injury in patients with sickle cell anemia. Kidney Int. 1996;49:686–91.
   Web of Science ®Google Scholar
• Nishank SS, Singh MP, Yadav R, Gupta RB, Gadge VS, Gwal A. Endothelial nitric oxide synthase gene polymorphism is associated with sickle cell disease patients in India. J Hum Genet. 2013;58:775–9. doi: 10.1038/jhg.2013.99
   PubMed Web of Science ®Google Scholar
• Tesauro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP, Moss J. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with tartrate vs. glutamate at position 298. Proc Natl Acad Sci USA. 2000;97:2832–5. doi: 10.1073/pnas.97.6.2832
   PubMed Web of Science ®Google Scholar
• Liu R, Geng P, Ma M, Yu S, Wang X, Zhang W, et al. Association between endothelial nitric oxide synthase gene polymorphism (T-786C) and ischemic stroke susceptibility: a meta-analysis. Int J Neurosci. 2014;124(9):642–51. doi: 10.3109/00207454.2013.873978
   PubMed Web of Science ®Google Scholar
• Ekmekçi A, Ozcan KS, Güngör B, Abaci N, Osmonov D, Zencirci A, et al. The relationship between endothelial nitric oxide synthase 4a/4b gene polymorphism and premature coronary artery disease. Acta Cardiol. 2013;68:464–8.
   PubMed Web of Science ®Google Scholar
• Tantawy AA, Adly AA, Ismail EA, Aly SH. Endothelial nitric oxide synthase gene intron 4 VNTR polymorphism in sickle cell disease: relation to vasculopathy and disease severity. Pediatr Blood Cancer. 2015;62(3):389–94. doi: 10.1002/pbc.25234
   PubMed Web of Science ®Google Scholar
• Thakur TJ, Guindo A, Cullifer LR, Li Y, Imumorin IG, Diallo DA, et al. Endothelin-1 but not endothelial nitric oxide synthase gene polymorphism is associated with sickle cell disease in Africa. Gene Regul Syst Biol. 2014;8:119–26. doi:10.4137/GRSB.S14836
   PubMedGoogle Scholar
• Vargas AE, da Silva MAL, Silla L, Chies JAB. Polymorphisms of chemokine receptors and eNOS in Brazilian patients with sickle cell disease. Tissue Antigens. 2005;66:683–90. doi: 10.1111/j.1399-0039.2005.00506.x
   PubMed Web of Science ®Google Scholar
• Sharan K, Surrey S, Ballas S, Borowski M, Devoto M, Wang KF, et al. Association of T-786C eNOS gene polymorphism with increased susceptibility to acute chest syndrome in females with sickle cell disease. Br J Hematol. 2004;124:240–3. doi: 10.1046/j.1365-2141.2003.04762.x
   PubMed Web of Science ®Google Scholar
• Chaar V, Tarer V, Etienne-Julan M, Diara JP, Elion J, Romana M. ET-1 and ecNOS gene polymorphisms and susceptibility to acute chest syndrome and painful vaso-occlusive crises in children with sickle cell anemia. Haematologica. 2006;91(9):1277–8.
   PubMed Web of Science ®Google Scholar
• Mack AK, Kato GJ. Sickle cell disease and nitric oxide: a paradigm shift? Int J Biochem Cell Biol. 2006;38:1237–43. doi: 10.1016/j.biocel.2006.01.010
   PubMed Web of Science ®Google Scholar
• Elshamaa MF, Sabry S, Badr A, El-Ahmady M, Elghoroury EA, Thabet EH, et al. Endothelial nitric oxide synthase gene intron 4 VNTR polymorphism in patients with chronic kidney disease. Blood Coagul Fibrinolysis. 2011;22:487–92. doi: 10.1097/MBC.0b013e328346ef71
   PubMed Web of Science ®Google Scholar